A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
We are honored to provide technology and services to help providers thrive, and that the HFMA panel awarded our solution Peer Review designation.
The future of life sciences is hurtling towards a digital revolution with emphasis on immediacy for the pharmaceutical, biopharmaceutical, and medical device technology value chain.
The power of RWD and RWE continues to play a key role in helping increase research efficiency and accelerate the introduction of new treatments.
Automated buying experience with complete visibility into procurement will help drive healthcare supply chain resiliency, savings opportunities and quality patient care across the care continuum.
More and more researchers are turning to actionable insights derived from the PINC AI™ Healthcare Database to further knowledge about cancer.
bioMérieux and PINC AI™ Applied Sciences collaborate to understand the epidemiology, HRU and costs related to AGE in adult patients.
Premier, Inc. announced that its Board of Directors is evaluating potential strategic alternatives to enhance value for stockholders.
Partnering with PINC AI™ Stanson’s clinical decision support (CDS) technology platform empowered a large health system in Missouri to significantly improve HCC coding accuracy.
The Cone Health team implemented the PINC AI™ Quality Enterprise to help with early sepsis recognition and to reduce mortality and cost.
Using data and technology to drive decisions around the right supplies, services and equipment for optimal care delivery, safety, outcomes and total cost.
Award winners demonstrated significantly higher survival rates associated with cardiac care, with fewer readmissions and complications.
Recognized for exceptional leadership and commitment to business integrity through best-in-class ethics, compliance and governance practices.